BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 26416858)

  • 21. Experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus treated with a polylactide carrier releasing linezolid.
    Tsiolis P; Giamarellos-Bourboulis EJ; Mavrogenis AF; Savvidou O; Lallos SN; Frangia K; Lazarettos I; Nikolaou V; Efstathopoulos NE
    Surg Infect (Larchmt); 2011 Apr; 12(2):131-5. PubMed ID: 21348763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite.
    Shirtliff ME; Calhoun JH; Mader JT
    Clin Orthop Relat Res; 2002 Aug; (401):239-47. PubMed ID: 12151901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model.
    Faber C; Stallmann HP; Lyaruu DM; Joosten U; von Eiff C; van Nieuw Amerongen A; Wuisman PI
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2438-44. PubMed ID: 15917544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local treatment of chronic osteomyelitis with surgical debridement and tigecycline-impregnated calcium hydroxyapatite: an experimental study.
    Kaya M; Şimşek-Kaya G; Gürsan N; Kireççi E; Dayi E; Gündoğdu B
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Mar; 113(3):340-7. PubMed ID: 22676826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel, multi-barrier, drug eluting calcium sulfate/biphasic calcium phosphate biodegradable composite bone cement for treatment of experimental MRSA osteomyelitis in rabbit model.
    Mistry S; Roy S; Maitra NJ; Kundu B; Chanda A; Datta S; Joy M
    J Control Release; 2016 Oct; 239():169-81. PubMed ID: 27582374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres.
    Cevher E; Orhan Z; Mülazimoğlu L; Sensoy D; Alper M; Yildiz A; Ozsoy Y
    Int J Pharm; 2006 Jul; 317(2):127-35. PubMed ID: 16624509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustainable release of vancomycin from micro-arc oxidised 3D-printed porous Ti6Al4V for treating methicillin-resistant Staphylococcus aureus bone infection and enhancing osteogenesis in a rabbit tibia osteomyelitis model.
    Zhang T; Wei Q; Zhou H; Zhou W; Fan D; Lin X; Jing Z; Cai H; Cheng Y; Liu X; Li W; Song C; Tian Y; Xu N; Zheng Y; Liu Z
    Biomater Sci; 2020 Jun; 8(11):3106-3115. PubMed ID: 32350485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of NEMO-binding domain peptide used to treat experimental osteomyelitis caused by methicillin-resistant
    Xu CP; Chen Y; Sun HT; Cui Z; Yang YJ; Huang L; Yu B; Wang FZ; Yang QP; Qi Y
    Antimicrob Resist Infect Control; 2019; 8():182. PubMed ID: 31832182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.
    Yan L; Jiang DM; Cao ZD; Wu J; Wang X; Wang ZL; Li YJ; Yi YF
    Drug Des Devel Ther; 2015; 9():3665-76. PubMed ID: 26213463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo osteogenic activity of the novel vancomycin-loaded bone-like hydroxyapatite/poly(amino acid) scaffold.
    Cao Z; Jiang D; Yan L; Wu J
    J Biomater Appl; 2016 May; 30(10):1566-77. PubMed ID: 26686585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis.
    Jacqueline C; Amador G; Caillon J; Le Mabecque V; Batard E; Miègeville AF; Biek D; Ge Y; Potel G; Hamel A
    J Antimicrob Chemother; 2010 Aug; 65(8):1749-52. PubMed ID: 20530506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of fosfomycin in experimental osteomyelitis due to methicillin-resistant Staphylococcus aureus.
    Poeppl W; Tobudic S; Lingscheid T; Plasenzotti R; Kozakowski N; Georgopoulos A; Burgmann H
    Antimicrob Agents Chemother; 2011 Feb; 55(2):931-3. PubMed ID: 21098253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo drug release and antibacterial properties of the novel vancomycin-loaded bone-like hydroxyapatite/poly amino acid scaffold.
    Cao Z; Jiang D; Yan L; Wu J
    Int J Nanomedicine; 2017; 12():1841-1851. PubMed ID: 28331309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gentamicin-loaded borate bioactive glass eradicates osteomyelitis due to Escherichia coli in a rabbit model.
    Xie Z; Cui X; Zhao C; Huang W; Wang J; Zhang C
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3293-8. PubMed ID: 23629702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of leukocyte- and platelet-rich plasma gel (L-PRP gel) in treating osteomyelitis in a rabbit model.
    Li GY; Yin JM; Ding H; Jia WT; Zhang CQ
    J Orthop Res; 2013 Jun; 31(6):949-56. PubMed ID: 23280538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model.
    Yin LY; Lazzarini L; Li F; Stevens CM; Calhoun JH
    J Antimicrob Chemother; 2005 Jun; 55(6):995-1002. PubMed ID: 15857944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo evaluation of teicoplanin- and calcium sulfate-loaded PMMA bone cement in preventing implant-related osteomyelitis in rats.
    Tuzuner T; Sencan I; Ozdemir D; Alper M; Duman S; Yavuz T; Yildirim M
    J Chemother; 2006 Dec; 18(6):628-33. PubMed ID: 17267341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
    Lefebvre M; Jacqueline C; Amador G; Le Mabecque V; Miegeville A; Potel G; Caillon J; Asseray N
    Int J Antimicrob Agents; 2010 Dec; 36(6):542-4. PubMed ID: 20851576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the efficacy of tigecycline and teicoplanin in an experimental methicillin-resistant Staphylococcus aureus osteomyelitis model.
    Kandemir O; Oztuna V; Colak M; Akdag A; Camdeviren H
    J Chemother; 2008 Feb; 20(1):53-7. PubMed ID: 18343744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tricalcium phosphate, an antibiotic carrier: a study focused on experimental osteomyelitis in rabbits].
    Lambotte JC; Thomazeau H; Cathelineau G; Lancien G; Minet J; Langlais F
    Chirurgie; 1998 Dec; 123(6):572-9. PubMed ID: 9922597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.